5243962025-04-012025-06-305243962025-06-305243962025-04-012025-06-30in-capmkt:OtherExpenses1Member5243962025-04-012025-06-30in-capmkt:OtherExpenses2Member5243962025-04-012025-06-30in-capmkt:OtherExpenses3Member5243962025-04-012025-06-30in-capmkt:ReportableSegments1Member5243962025-04-012025-06-30in-capmkt:ReportableSegments2Member5243962025-04-012025-06-30in-capmkt:ReportableSegments1Member5243962025-04-012025-06-30in-capmkt:ReportableSegments2Member5243962025-04-012025-06-30in-capmkt:ReportableSegments1Member5243962025-06-30in-capmkt:ReportableSegments1Member5243962025-04-012025-06-30in-capmkt:ReportableSegments2Member5243962025-06-30in-capmkt:ReportableSegments2Member5243962025-04-012025-06-30in-capmkt:ReportableSegments1Member5243962025-06-30in-capmkt:ReportableSegments1Member5243962025-04-012025-06-30in-capmkt:ReportableSegments2Member5243962025-06-30in-capmkt:ReportableSegments2Memberiso4217:INRiso4217:INRxbrli:shares524396BIOFILCHEMNOTLISTEDINE829A01014BIOFIL CHEMICALS & PHARMACEUTICALS LIMITEDMain BoardEquity2025-04-012026-03-312025-08-122025-08-04INRLakhsQuarterlyFirst quarterMulti segment2025-08-1216:00:002025-08-1217:50:00Not applicablefalsefalseNot Applicable <BR> 2025-04-012025-06-30UnauditedStandalone6432600028320000926460001171400097406000-4979100021040009300066000028350006502100027625000027625000351500003515000024110000000024110000024110000162738000101.481.48001.481.481. The above Un-Audited Financial Results for the Quarter ended June 30, 2025 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in it's meeting held on 12th August, 2025. The above results have been reviewed by Statutory Auditors of the company in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company's Management has exercised necessary due diligence to ensure that the financial results provide a true and fair view of its affairs. <BR> <BR> 2. This financial results has been prepared in accordance with the guidelines issued by the Securities Exchange Board of India (SEBI) and Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) prescribed under Section 133 of the Companies Act, 2013 and other recognized accounting practices and policies to the extent applicable. <BR> <BR> 3. The figures of the previous period / year have been re-stated/ re-grouped / re-arranged/ reclassified and / or recasted wherever found necessary. <BR> <BR> 4. The Company has reported segment wise information as per Indian Accounting Standard (Ind AS-108). The Operations of the Company are conducted within India, there is no separate reportable geographical segment and the company reported the following business segments <BR> a. Pharma Product <BR> b. Chemicals Division <BR> <BR> 5. The aforesaid un-audited Financial Results will be uploaded on the Company’s website www.biofilgroup.net and will also be available on the websites of the Stock exchanges i.e. www.bseindia.com and www.nseindia.com for the benefit of shareholders and investors. Further, publication containing a Quick Response code and the details of the webpage where complete financial results of the Company are available, will be published in English and Hindi Newspapers with in prescribed time limit. <BR> <BR> 6. The figures for the quarter ended March 31, 2025 are the balancing figures between the audited figures in respect of the full financial year and the years to date figures up to the third quarter which were subjected to limited review. <BR> <BR> 7. The net profit of the Company for the quarter ended 30th June, 2025 has been increased due to disposal of undertaking situated at 11/12, Sector 'E', Sanwer Road Industrial Area, Indore – 452015 Madhya Pradesh after obtaining the approval from the members of the company .Other Expenses1683000Manufacturing Expenses567000Administrative Expenses585000Pharma Division48475000Chemical Division1585100064326000064326000Pharma Division26974000Chemical Division7370002771100086000027625000Pharma Division348158000Chemical Division1627230005108810000510881000Pharma Division229092000Chemical Division698620002989540000298954000000